Philanthropic Support to Address Hiv/Aids in 2015 Our Mission
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Annual Report 2012 NSI NV
annual report 2012 NSI N.V. annual report 2012 NSI N.V. 3 annual report NSI 2012 This version of NSI’s annual report is a translation of the original Dutch version. Although this English version has been compiled with the utmost care, in case of discrepancies between the English and the Dutch version, the Dutch version will prevail. Colofon This annual report is a publication by NSI. NSI Kruisweg 661-665 t +31 20 76 30 300 2132 NC Hoofddorp f +31 20 25 81 123 P.O. Box 3044 [email protected] 2130 KA Hoofddorp www.nsi.nl Editing and texts NSI Concept and design Bfocussed, Rotterdam Illustrations and icons Bfocussed, Rotterdam Prints Zwarthoed, Volendam Paper This publication is printed on PEFC certified paper. For additional information about NSI: www.nsi.nl 4 General data Supervisory Board H. Habas, chairman H.J. van den Bosch, secretary H.W. Breukink G.L.B. de Greef W.M. Steenstra Toussaint Management Board J. Buijs, ceo D.S.M. van Dongen, cfo General Meeting of Shareholders The General Meeting of Shareholders will be held on Friday 26 April 2013 at 10:30 am in Theatre Het Park, Westerdijk 4 in Hoorn. The agenda fort his meeting is available from the company. Financial Calendar 2013 AGM 26 April 2013 Publication first quarter results 2013 17 May 2013 Publication first half year results 2013 9 Augustus 2013 Publication third quarter results 2013 8 November 2013 Interim-dividends payments 2013 * Setting of final dividend for 2012 26 April 2013 Listing ex-dividend 30 April 2013 Payment of final dividend for 2012 8 May 2013 Setting of Q1 2013 interim -
Critical Actions from 2012-2016 to Begin to End the HIV/AIDS Pandemic
An Action Agenda to End AIDS EMBARGOED Critical Actions UNTIL THURSDAY, JULY 19 AT NOON ET from 2012-2016 to Begin to End the HIV/AIDS Pandemic JULY 2012 ver the last year, the conversation about the AIDS transmission. We emphasize, too, that comprehensive • Focused, Evidence-Based Prevention Programs epidemic has dramatically changed. We’re now harm reduction, decriminalization and human rights for Key Populations—to ensure that drivers of O beginning to talk about how to end it. The hope protections must be combined to effectively address the the epidemic are addressed. stems from research breakthroughs as well as an epidemics among injection drug users, men who have accumulation of evidence on the potential impact of sex with men (MSM) and sex workers around the world. To end the epidemic, we cannot do everything in “combination prevention,” which the US government Failure to implement these strategies at scale remains every setting. Nor can we look to limited AIDS has defined as including voluntary medical male a major missed opportunity of HIV prevention to date. funding to address all the many ills that undermine circumcision, the use of ART treatment in HIV-positive health and development. Core interventions people to reduce risk of transmission prevention of As the concept of combination prevention takes should be complemented, where indicated by pediatric infections and HIV testing. hold, there will inevitably be debates about which local circumstances, by other strategies, such as “America’s combination prevention strategy focuses on a interventions to prioritize. We believe the test should condom promotion, harm reduction, behavior set of interventions that have been proven most effective To begin to end the epidemic, we need to be strategic be to identify the cost-effective approaches that will best change strategies, demonstration projects for pre- — ending mother-to-child transmission, expanding and ambitious in using what is available today. -
Brand Guidelines for Partners 2019
BRAND GUIDELINES 2019 P. 2 (RED) BRAND GUIDELINES 2019 HELLO. Good to have you! (RED) is a nonprofit organization that fights AIDS. 100% of all proceeds generated from Partners go directly to The Global Fund, which distributes the money to work on the ground in Ghana, Kenya, Lesotho, Rwanda, South Africa, Swaziland, Tanzania, and Zambia. We believe a strong brand keeps us inspiring and relevant, and can help you tell your story better, too. These guidelines should educate you on (RED) and equip you to message about us in the best ways possible. P. 3 (RED) BRAND GUIDELINES 2019 (RED) CONTENT OVERVIEW ABOUT FOR PARTNERS 4. Our Story 23. Partner Logos 6. Our Progress 24. Partnership Language 8. Our Partners 27. Packaging Guidelines 29. Partner Cheat Sheet THE BRAND 11. Brand Lens ASSETS + CONTACT 12. Our Logos 30. Assets 14. Registration 31. Say Hello 15. Copyright 16. Typefaces 17. Color 18. The Parentheses 19 (RED) Words 20. Language & Tone P. 4 OUR STORY (RED) was created by Bono and Bobby Shriver in 2006 to transform the collective power of consumers into a global force of critical, lifesaving aid. (RED) BRAND GUIDELINES 2019 We work with the world’s most iconic brands— including Apple, Starbucks, Belvedere Vodka, Bank of America, and more—to develop (PRODUCT)RED branded products and experiences that, when purchased, trigger corporate giving to the Global Fund. With these contributions, the Global Fund finances programs in sub-Saharan Africa, which provide HIV+ pregnant women access to the lifesaving medication they need to ensure their babies are born HIV-free. -
Abstract Supplement
ONLINE ONLINE OPEN PEER-REVIEWD PEER-REVIEWD ONLINE A PEER-REVIEWD OPEN ACCESS OPEN HIV/AIDS JOURNAL HIV/AIDS JOURNAL CCESS ONLINEONLINE CCESS A OPEN OPEN PEER-REVIEWD ONLINE HIV/AIDS JOURNAL HIV/AIDS HIV/AIDS JOURNAL PEER-REVIEWD PEER-REVIEWD OPEN ACCESSONLINEPEER-REVIEWD A ONLINEPEER-REVIEWD CCESS HIV/AIDS JOURNALPEER-REVIEWD OPEN ACCESS CCESS A OPEN ONLINE ONLINE HIV/AIDS JOURNAL ONLINE PEER-REVIEWDHIV/AIDS JOURNALONLINEONLINE PEER-REVIEWDOPEN ACCESS PEER-REVIEWD ONLINE ONLINE OPEN ACCESSONLINE OPEN HIV/AIDS JOURNAL CCESS OPEN ACCESS HIV/AIDS JOURNAL PEER-REVIEWD PEER-REVIEWD PEER-REVIEWD HIV/AIDS JOURNAL PEER-REVIEWD A HIV/AIDS JOURNAL OPEN ACCESS PEER-REVIEWD PEER-REVIEWD PEER-REVIEWDONLINE HIV/AIDS JOURNAL HIV/AIDS JOURNAL OPEN ACCESS ONLINE ONLINEONLINE HIV/AIDS JOURNAL HIV/AIDS PEER-REVIEWD A PEER-REVIEWD ONLINE ONLINE HIV/AIDS JOURNAL CCESS HIV/AIDS JOURNALOPEN ONLINE PEER-REVIEWDONLINE PEER-REVIEWD HIV/AIDS JOURNAL OPEN PEER-REVIEWDJOURNAL HIV/AIDS HIV/AIDS JOURNAL HIV/AIDS JOURNAL CCESS ONLINE A A ONLINE OPEN ACCESS HIV/AIDS JOURNAL ONLINE HIV/AIDS JOURNAL CCESS PEER-REVIEWD OPEN ACCESS HIV/AIDS JOURNAL OPEN ACCESS ONLINE HIV/AIDS JOURNAL HIV/AIDS ONLINE OPEN OPEN ACCESS HIV/AIDS JOURNAL PEER-REVIEWD OPEN HIV/AIDS JOURNALPEER-REVIEWD PEER-REVIEWD OPEN ACCESS PEER-REVIEWD CCESS A OPEN PEER-REVIEWDONLINE PEER-REVIEWD PEER-REVIEWD HIV/AIDS JOURNALAbstractHIV/AIDS JOURNAL SupplementHIV/AIDS JOURNAL PEER-REVIEWD OPEN ACCESS CCESS PEER-REVIEWD A PEER-REVIEWD Oral abstracts of the 21st International AIDS Conference A CCESS OPEN ACCESS -
UNAIDS/WHO (2008) Report on the Global HIV/AIDS Epidemic
Report on the 08 global AIDS epidemic Executive summary UNAIDS/08.27E / JC1511E (English original, July 2008) © Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008. All rights reserved. Publications produced by UNAIDS can be obtained from the UNAIDS Content Management Team. Requests for permission to reproduce or translate UNAIDS publications—whether for sale or for noncommercial distribution—should also be addressed to the Content Management Team at the address below, or by fax, at +41 22 791 4187, or e-mail: [email protected]. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of UNAIDS concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specifi c companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by UNAIDS in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. UNAIDS does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. Cover photo: UNAIDS / N. Lieber WHO Library Cataloguing-in-Publication Data Report on the global HIV/AIDS epidemic 2008: executive summary. “UNAIDS/08.27E / JC1511E”. 1.HIV infections − epidemiology. 2.HIV infections − therapy. 3.Acquired immunodefi ciency syndrome − epidemiology. 4.Acquired immunodefi ciency syndrome − prevention and control. -
Better (Red)™ Than Dead? Celebrities, Consumption and International Aid Richey, Lisa Ann; Ponte, Stefano
Better (Red)™ Than Dead? Celebrities, Consumption and International Aid Richey, Lisa Ann; Ponte, Stefano Document Version Accepted author manuscript Published in: Third World Quarterly DOI: 10.1080/01436590802052649 10.1080/01436590802052649 Publication date: 2008 License Unspecified Citation for published version (APA): Richey, L. A., & Ponte, S. (2008). Better (Red)™ Than Dead? Celebrities, Consumption and International Aid. Third World Quarterly, 29(4), 711-729. https://doi.org/10.1080/01436590802052649, https://doi.org/10.1080/01436590802052649 Link to publication in CBS Research Portal General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Take down policy If you believe that this document breaches copyright please contact us ([email protected]) providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Post-print of Richey, L. A. and Ponte, S. (2008) “Better REDTM than Dead? Celebrities, Consumption and International Aid”, Third World Quarterly, Vol. 29, No. 4, pp. 711-729. DOI: 10.1080/01436590802052649 Stable URL to publisher: http://www.tandfonline.com/doi/abs/10.1080/01436590802052649#.VCp9Fi5_sgE BETTER (RED)™ THAN DEAD? CELEBRITIES, CONSUMPTION AND INTERNATIONAL AID Introduction Bono’s launch of Product (RED)TM at Davos in 2006 opens a new frontier for development aid. Product RED is ‘a brand created to raise awareness and money for The Global Fund by teaming up with iconic brands to produce RED-branded products’.1 Consumption, trade, and aid wed dying Africans with designer goods. -
1 0 0 0 C O M P a N Ie S T O in S P Ir E Eu R O
1000 COMPANIES TO INSPIRE EUROPE INSPIRE TO COMPANIES 1000 2017 Our sponsors In association with www.1000companies.com LSEG London Stock Exchange Group Editorial Board Lauren Crawley-Moore (Head of Marketing Campaigns & Events); Alexandra Ritterman (Press Officer); Carolina Avanzini (Elite Growth Europe Associate); Damilola Alli (Marketing Associate) Contents Research & data verification and company profile editorial Business for Growth Ltd (organisers of the European Business Awards) Forewords www.businessawardseurope.com 4 A strengthened Capital Markets Union 58 Backing Europe’s SMEs to focus on the EU’s underperforming Michael Collins, CEO, Invest Europe IPO market 70 Dynamic SMEs need financing Valdis Dombrovkis, Vice-President European Sirpa Pietikäinen MEP, European Parliament Wardour Commission, Euro and Social Dialogue, Led by Claire Oldfield (Managing Director) and Ben Barrett (Creative Director). Financial Stability, Financial Services and CMU 82 Investing to meet the challenges ahead The team included: Matt Williams (Art Director); Rob Clark (Editor) and Wardour editorial; Othmar Karas MEP, European Parliament 5 Inside the report Jennifer Flower and Charlotte Tapp (Project Directors); John Faulkner and Jack Morgan (Production). Xavier Rolet KBE, CEO, 90 The Elite route to success Wardour, Drury House, 34–43 Russell Street, London, WC2B 5HA, United Kingdom London Stock Exchange Group Luca Peyrano, CEO, ELITE +44 (0)20 7010 0999 www.wardour.co.uk 8 Estonia will be committed to 108 Capital market finance remains helping SMEs neglected -
"SOLIZE India Technologies Private Limited" 56553102 .FABRIC 34354648 @Fentures B.V
Erkende referenten / Recognised sponsors Arbeid Regulier en Kennismigranten / Regular labour and Highly skilled migrants Naam bedrijf/organisatie Inschrijfnummer KvK Name company/organisation Registration number Chamber of Commerce "@1" special projects payroll B.V. 70880565 "SOLIZE India Technologies Private Limited" 56553102 .FABRIC 34354648 @Fentures B.V. 82701695 01-10 Architecten B.V. 24257403 100 Grams B.V. 69299544 10X Genomics B.V. 68933223 12Connect B.V. 20122308 180 Amsterdam BV 34117849 1908 Acquisition B.V. 60844868 2 Getthere Holding B.V. 30225996 20Face B.V. 69220085 21 Markets B.V. 59575417 247TailorSteel B.V. 9163645 24sessions.com B.V. 64312100 2525 Ventures B.V. 63661438 2-B Energy Holding 8156456 2M Engineering Limited 17172882 30MHz B.V. 61677817 360KAS B.V. 66831148 365Werk Contracting B.V. 67524524 3D Hubs B.V. 57883424 3DUniversum B.V. 60891831 3esi Netherlands B.V. 71974210 3M Nederland B.V. 28020725 3P Project Services B.V. 20132450 4DotNet B.V. 4079637 4People Zuid B.V. 50131907 4PS Development B.V. 55280404 4WEB EU B.V. 59251778 50five B.V. 66605938 5CA B.V. 30277579 5Hands Metaal B.V. 56889143 72andSunny NL B.V. 34257945 83Design Inc. Europe Representative Office 66864844 A. Hak Drillcon B.V. 30276754 A.A.B. International B.V. 30148836 A.C.E. Ingenieurs en Adviesbureau, Werktuigbouw en Electrotechniek B.V. 17071306 A.M. Best (EU) Rating Services B.V. 71592717 A.M.P.C. Associated Medical Project Consultants B.V. 11023272 A.N.T. International B.V. 6089432 A.S. Watson (Health & Beauty Continental Europe) B.V. 31035585 A.T. Kearney B.V. -
Macrophages Provide a Transient Muscle Stem Cell Niche Via NAMPT Secretion
Article Macrophages provide a transient muscle stem cell niche via NAMPT secretion https://doi.org/10.1038/s41586-021-03199-7 Dhanushika Ratnayake1,2, Phong D. Nguyen3,4,11, Fernando J. Rossello1,5,11, Verena C. Wimmer6,7,11, Jean L. Tan1,2,11, Laura A. Galvis1,9, Ziad Julier1,2, Alasdair J. Wood1,2, Received: 20 June 2019 Thomas Boudier6,7, Abdulsalam I. Isiaku1, Silke Berger1,2, Viola Oorschot8,10, Accepted: 7 January 2021 Carmen Sonntag1,2, Kelly L. Rogers6,7, Christophe Marcelle1,9, Graham J. Lieschke1, Mikaël M. Martino1,2,12, Jeroen Bakkers3,4,12 .& Peter D Currie1,2 ✉ Published online: xx xx xxxx Check for updates Skeletal muscle regenerates through the activation of resident stem cells. Termed satellite cells, these normally quiescent cells are induced to proliferate by wound-derived signals1. Identifying the source and nature of these cues has been hampered by an inability to visualize the complex cell interactions that occur within the wound. Here we use muscle injury models in zebrafsh to systematically capture the interactions between satellite cells and the innate immune system after injury, in real time, throughout the repair process. This analysis revealed that a specifc subset of macrophages ‘dwell’ within the injury, establishing a transient but obligate niche for stem cell proliferation. Single-cell profling identifed proliferative signals that are secreted by dwelling macrophages, which include the cytokine nicotinamide phosphoribosyltransferase (Nampt, which is also known as visfatin or PBEF in humans). Nampt secretion from the macrophage niche is required for muscle regeneration, acting through the C-C motif chemokine receptor type 5 (Ccr5), which is expressed on muscle stem cells. -
Meet Your Bugaboo Fox GO TO: IMPORTANT INFORMATION
GO TO: IMPORTANT INFORMATION meet your bugaboo fox GO TO: IMPORTANT INFORMATION 4x 4x 4x 4x 2 GO TO: IMPORTANT INFORMATION 3 GO TO: IMPORTANT INFORMATION A B F C G H D E I J K L M V N O P Q W R X S Y T U * product depicted may not be exactly the same in all regions 4 GO TO: IMPORTANT INFORMATION A. handlebar K. swivel wheel U. large wheel release button B. chassis L. integrated attachment point 1 V. sun canopy C. carry handle release button M. wrist strap W. square white knob D. large wheel N. apron X. unfolding lock E. underseat bag O. handlebar adjustment clip Y. suspension F. carry handle P. integrated attachment point 2 G. seat Q. bassinet stiffener H. harness R. bassinet/carrycot/pram body I. swivel wheel release button S. brake J. swivel wheel lock T. integrated attachment point 3 visual check OK visual check wrong audible click 1 2 3 Perform action on both sides of the product. 4 5 6 video available 7 5 GO TO: IMPORTANT INFORMATION When you see this symbol in the instructional part of the user guide, please refer to the warnings chapter for ensuring the safe use of the Bugaboo Fox. All the white parts of your Bugaboo Fox are functional. They’re the parts that allow you to adapt and change your Bugaboo Fox. 6 GO TO: IMPORTANT INFORMATION 16 22 19 26 20 28 31 34 35 36 38 40 41 43 44 8 GO TO: IMPORTANT INFORMATION 45 46 48 49 51 52 54 55 56 57 58 59 61 9 1 2 3 GO TO: IMPORTANT INFORMATION 4 5 6 7 33 34 35 36 37 38 39 4000 4x 4x 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 01 02 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 03 10 GO TO: IMPORTANT INFORMATION -
DBA Inteliigence Publications Titles with Fol Exemptions Second
DBA IntelIigence Publications Titles with FOl Exemptions Second Section 1997 - 2015 As of july 25. 2015 Prod- No. Title Year 01005 (b)(7')(A) Coca Cultivation & Cocaine Base Production 2001 01015 Cultivio de Coca y Producción 2001 studies in (b)(7)(A) | 02036 2002 NPMP-142 (b)(7)(A) Marijuana Routes 2003 NPMP-142 Money Laundering Routes 2003 NPMP-142 Methamphetamine Routes 2003 NPMP-142 Pharmaceutical Routes 2003 04039 Methamphetamine and Chemical Diverson Situation! (b)7)(A) | 2004 05007 (b)(7)(A) Technical Notes, First Edition 2005 05019 |(b)(7 )Coca Yields 2005 06002 Technical Motes 2006 06019 Opium Poppy Cultivation and Heroin Production inf (b)(7)(A) 2006 NPMP-102 (b)(7)(A) | Cocaine Routes 2006 (b)(7)(A) | Cocaine Base Processing m the| (b)(7)(A) | 07022 2007 DIB-004-07 |an^ (b)(7)(A) Traffickers Expand Ties in the Methamphetamine Trade 2007 DIB-005-07 (b)(7)(A) The New Front Line in the Battle for the Border 2007 Jo t (b)(7)(A) |5tudy to Estimate Coca Leaf Yields in the| (b)(r)(A) Region of (b)(7)(A) 08014 in 2008 08024 Drug Related Deaths (b)(''HA) |Aiea of Responsibility (Unclassified) 2008 08027 (b)(7)(A) Studies to Estimate Coca Leaf Yields in the (b)(7)(A) Growing Regions of Arauca and Vichada 2008 08029 Dictionary 2008 Joint (b)(7)(A) Study to Estimate Coca Leaf Yields in he (b)(7)(A) of (b)(7)(A) 08041 t 2008 09005 (b)( 7 )(A) Study to Estimate Coca Leaf YieIds i n the (b)(7)( | Regio ns of (b)(7)(A) ] 2009 09010 Study to Estimate Coca Leaf Yields in the) (b)(7)(A) |Regian of| (b)(7)(A) | 2009 09014 (b)(7) |Heroin Assessment -
Product Launch Improvement at Bugaboo International
Product launch improvement at bugaboo international By André van Wijhe bachelor assignment André van Wijhe bugaboo international operations and innovations department September 2008 – June 2010 Amsterdam Zuid-Oost, The Netherlands Product launch improvement at bugaboo international Bachelor thesis final report André van Wijhe s0027871 Business Administration University of Twente First supervisor: Prof. dr. ir. P.C. de Weerd-Nederhof Second supervisor: Dr. ir. P. Terlouw Supervisor: R.J. Smeding - 1 - bachelor assignment André van Wijhe Preface - 2 - bachelor assignment André van Wijhe Management Summary Bugaboo international is a fast growing, young and innovative stroller company. Because of its explosive growth in the past couple of years, a structured NPD process has just been in use. A research concerning improvements of launch plans for bugaboo was the aim of this assignment. Therefore the central problem definition in this research is formulated as follows: For bugaboo it is unclear what good strategies are to launch new products. The focus of this research lies on the entire product portfolio of bugaboo international and this has resulted in the main question: What are good launch strategies for bugaboo? In this main question the word strategies embraces the entire launch plan of a new bugaboo product. With the use of interviews with bugaboo employees, a focus group meeting with a number of employees and a literature study on product launches, the necessary data was gathered. After an analysis, this resulted in the creation of the bugaboo launch model. That model represents the steps that need to be taken into account when launching a new bugaboo product.